In collaboration with the University of Toronto Centre for the Study of Pain, the Faculty of Dentistry, Leslie Dan Faculty of Pharmacy, Lawrence Bloomberg Faculty of Nursing and the Temerty Faculty of Medicine invite you to The Future of Pain.
Date: Wednesday, March 9, 2022
Time: 7:00 p.m. – 8:30 p.m.
YouTube link will be provided prior to presentation.
This webinar will feature presentations covering a range of pain-related research from
graduate students in each faculty.
A Q&A session will be held at the end of the presentation, moderated by Dr. Robert Bonin, BSc, PhD’10,
Co-Director for the University of Toronto’s Centre for the Study of Pain (UTCSP), and Assistant Professor, Leslie Dan Faculty of Pharmacy, and Dr. Rachael Bosma, Hon BSc, PhD, Co-Director for the University of Toronto’s Centre for the Study of Pain (UTCSP), and Assistant Professor, Faculty of Dentistry.
Georgia Hadjis, BSc
PhD student at the Faculty of Dentistry
Georgia’s research is focused on understanding how pain impacts cognition, with the goal of reducing this impact and improving patients’ lives.
Pain affects one in five Canadians and costs an estimated $60 billion each year. Pain can impact our ability to concentrate, our attention, memory and decision-making ability—collectively known as cognition. This affects the ability to work and fully participate in society.
Lauren Cadel, BSc, MSc
Leslie Dan Faculty of Pharmacy
Lauren’s research is focused on exploring pain and medication management among adults with spinal cord injury in Ontario, Canada.
PhD student at the Lawrence Bloomberg Faculty of Nursing
Franklin’s research focuses on multidimensional experience of pain in adults with advanced liver disease.
Unrelieved pain is a significant problem for adult patients living with advanced liver disease. The overall aim of this research study is to examine pain from a multidimensional perspective for patients with advanced liver disease.
MSc student at the Temerty Faculty of Medicine
Prabjit’s research is focused on investigating the relationship between medical cannabis use and inflammatory cytokines and chemokines among adult chronic pain patients.
With the trend towards cannabis legalization in North America, interest in cannabis as a potential therapeutic option for some chronic pain patients has grown. However, investigations of cannabis’ potential immune system effects remain scarce. Our research is focused on characterizing the relationship between medical cannabis use and immune cells, as well as inflammation, among chronic pain patients using medical cannabis. The results of our research will provide investigators and clinicians insights on how cannabis can potentially provide pain relief through immune system mechanisms.